
Eli Lilly Begins $3.5B Lehigh Valley Manufacturing Plant in Upper Macungie
Eli Lilly has started construction on a $3.5 billion manufacturing campus in Upper Macungie, a Lehigh Valley community in Pennsylvania. The complex will span roughly 925,000 square feet spread across several buildings and will support production of injectable medicines and other medical devices.
The company is projected to add about 850 permanent jobs in the region, while the build-out is expected to support around 2,000 construction positions. Lilly bought the property at 9802 Main St., known as the Fogelsville Corporate Center, from Jaindl Land Development earlier this year, according to local reporting.
The project was announced earlier in the year with state backing. Pennsylvania Governor Josh Shapiro said the state committed more than $100 million in incentives, including $50 million in tax credits. Lehigh Carbon Community College is also set to receive state funding to expand life sciences training programs that will feed Lilly's hiring pipeline.
For developers and lenders, the deal signals sustained demand for large-format pharmaceutical manufacturing space in the Lehigh Valley, with incentive-backed projects likely to shape local industrial and workforce planning.
More in Pennsylvania
· West Whiteland, Pennsylvania
Court Lets Exton Square Mall Mixed-Use Redevelopment Move Forward
· Bethlehem, Pennsylvania
Bethlehem Cold Storage Building Nears Finish for J.G. Petrucci
· Plymouth Meeting, Pennsylvania
Developer Converts Obsolete Plymouth Meeting Office Into Shallow-Bay Industrial
· Philadelphia, Pennsylvania
Gridmark Adds 88 Residential Units to Center City West Walnut Street Plan
· Philadelphia, Pennsylvania
SEPTA Chief Says Expanded Transit Service Will Lure Employers and Housing to Philadelphia